HINJ 2013 Economic Impact Report

Download ‘HINJ’s 2013
Economic Impact Report’

HINJ and New Jersey's Life Sciences Community Brochure

Download HINJ and New
Jersey’s Life Sciences Community

 

 

Building-Bridges

Download the Report

Save the Date! HINJ to Host 2015 Life Sciences Celebration on October 30

HINJ Celebration 2015 STD

Please mark your calendar to join HINJ in honoring meritorious leadership in and contributions to New Jersey’s life sciences community at HINJ’s 2015 Life Sciences Celebration, which will be held Friday, October 30 at the Wyndham Garden Trenton from 8:00 to 10:00 a.m. 

Additional information — including HINJ’s 2015 honorees and online registration — will be announced shortly.

For the full story, which includes past HINJ honorees, click here.

 

HINJ Updates Portal of Member Companies’ Corporate Social Responsibility and Sustainability Activities

CSR chasing arrows

HINJ has updated its online portal to HINJ member companies’ myriad corporate social responsibility (CSR) activities, including their corporate philanthropy, patient outreach initiatives and sustainability/green practices

Launched in November 2014 and promoted via Twitter, Facebook and LinkedIn, HINJ’s CSR online portal has become one of the most-visited areas of our website

The portal — “HINJ Members’ CSR Activities” — is accessible by clicking on the second tab under the HINJ homepage’s Corporate Social Responsibility menu

For the complete story, click here.

 

HINJ APPLAUDS U.S. HOUSE PASSAGE OF THE 21st CENTURY CURES ACT

Cures 2015

HINJ issued a statement regarding the passage of the 21st Century Cures Act in the U.S. House of Representatives on July 10.

“[HINJ] applauds the U.S. House of Representatives’ passage of the 21st Century Cures Act,” HINJ said.

“This landmark legislation would accelerate the pace of discovering new, life-saving treatments and cures for some of the world’s most dreaded diseases,” HINJ said.  “It is vitally important to New Jersey’s life sciences community, where much of this research and discovery takes place, and it is critical to patients around the world who will benefit from its impact.”

“Our state is fortunate to have two New Jersey Members of Congress who played key leadership roles in the development of the 21st Century Cures Act,” HINJ continued.  “We commend Congressmen Frank Pallone, Jr. (D-6) and Leonard Lance (R-7) for their commitment to patients through their work to modernize America’s apparatus for researching, reviewing and approving new life-saving medical therapies, technologies and devices.”

To read HINJ’s complete #Cures2015 statement, click here.

 

NJ SPOTLIGHT PUBLISHES HINJ OP-ED: ‘CONGRESS NEEDS TO FIX FLAW IN LAWS GOVERNING LIFE-SCIENCES PATENTS’

Dean J. Paranicas -- HINJ President & Chief Executive Officer (low-res)

Dean J. Paranicas, President and Chief Executive Officer, HINJ

NJ Spotlight has published an op-ed authored by HINJ President and Chief Executive Officer Dean Paranicas on the subject of patent reform legislation currently pending before the U.S. House of Representatives.  Paranicas writes:

[Life sciences companies] depend on a strong, robust patent system to protect the intellectual property needed to discover these treatments and cures. 

“In 2011, Congress passed, with bipartisan support, the America Invents Act (AIA) …. However, the implementation of specific provisions of the AIA has unintentionally — and unfairly — put patent holders at a disadvantage. …

“Life-sciences companies support efforts to curb the abusive practices of patent trolls, and we will work with Congress to craft legislation that strikes the right balance without undermining the ability of legitimate patent holders to enforce their rights.”

To read Paranicas’ complete op-ed piece, click here.

 

LT. GOV. GUADAGNO OPENS NJPAC-HINJ LIFE SCIENCES BUSINESS ROUNDTABLE; PANEL EXPLORES NJ’S INNOVATION ECOSYSTEM

Lt. Governor Kim Guadagno speaks at NJPAC-HINJ Life Sciences Business Roundtable June 23

Lt. Governor Kim Guadagno speaks at NJPAC-HINJ Life Sciences Business Roundtable June 23

Highlighting New Jersey’s leadership as a home for innovation and as the “Medicine Chest of the World,” Lt. Governor Kim Guadagno on June 23 addressed the New Jersey Performing Arts Center’s (NJPAC) Business Partners “Life Sciences and New Jersey’s Innovation Ecosystem” Roundtable, presented in association HINJ.

Following the Lt. Governor’s opening address, HINJ President and Chief Executive Officer Dean Paranicas moderated a panel that featured:

  • Vincent A. Forlenza, Chairman of the Board, Chief Executive Officer and President, BD (Becton, Dickinson & Company)
  • Brenton L. Saunders, CEO and President, Allergan plc
  • Christopher J. Molloy, Ph.D, R.Ph., Senior Vice President, Research and Economic Development, Rutgers, The State University of New Jersey

For the complete story, click here.

 

GOVERNOR, LT. GOVERNOR, HINJ AND OTHER INDUSTRY LEADERS PROMOTE NJ LIFE SCIENCES IN CHOOSENJ VIDEO

Video ChooseNJ 20150618

HINJ President and Chief Executive Officer Dean J. Paranicas was one of the state leaders included in Choose New Jersey’s new video — “Leaders Choose New Jersey: Highly Educated, Perfectly Located” — that premiered at the 2015 BIO International Convention, which was held June 15-18 in Philadelphia.

Other New Jersey leaders appearing in the video to promote the state as a winning place for life sciences companies to invest are Governor Chris Christie, Lt. Governor Kim Guadagno, Michele Brown of ChooseNJ, Aaron Graff of Ferring Pharmaceuticals, Debbie Hart of BioNJ, Dr. Chris Molloy of Rutgers University, and Dr. Jay Tischfield of RUCDR Infinite Biologics.

To view the 4:17-minute video, click here

For the complete story, click here.  .

 

HINJ COMMENDS REPS. PALLONE’s AND LANCE’s LEADERSHIP ON ‘cures 2015′ ACTCures 2015

Andrew Kitchenman reports in NJ Spotlight that the U.S. House of Representatives’ 21st Century Cures Act is attracting bipartisan support — including from New Jersey sponsors Reps. Frank Pallone (D-6) and Leonard Lance (R-7) — and is drawing praise across New Jersey’s research community, as well as its biotechnology and pharmaceutical industries.

HINJ President and Chief Executive Officer Dean Paranicas commended Congressmen Pallone and Lance for their leadership, and said that the Cures 2015 bill is “vitally important to New Jersey’s life sciences community, but more importantly, to patients around the world.”

Paranicas singled out the FDA Safety Over Sequestration (SOS) (H.R. 1078) provisions sponsored by Congressman Lance.

For the complete story, click here.

 

HINJ AND BIONJ COMMENTARY: TO SAVE PATIENTS, KEEP NJ LIFE SCIENCES SECTOR HEALTHYCure Ahead 2

The Courier-Post has published an op-ed authored by Debbie Hart, BioNJ President and CEO, and Dean J. Paranicas, HINJ President and Chief Executive Officer.  Hart and Paranicas serve as two of the co-chairs of We Work for Health New Jersey.

“New Jersey’s representatives in Washington have long recognized the importance of fostering and protecting the innovation environment that is critical to finding the next generation of treatments and cures,” Hart and Paranicas wrote.

“We urge our policymakers to continue protecting patients and New Jersey’s economy by rejecting ill-conceived and anti-innovation proposals that could detrimentally impact our state’s economic well-being, and, more importantly, patients’ well-being here at home and around the globe,” they concluded.

To read the full op-ed, click here.

 

 

NJBIZ INTERVIEW:  HINJ CEO SAYS STOPPING THE ‘BRAIN DRAIN’ IS KEY TO RESTARTING NJ ECONOMY

Dean Paranicas -- NJBIZ March - CROPPED

HINJ President and CEO Dean Paranicas

In an interview with NJBIZ’s Andrew Sheldon, HINJ President and Chief Executive Officer Dean Paranicas underscored a potential threat to the often-touted workforce that makes up the state’s strong life sciences industry.

“Certainly, we are working — if you look at what’s been happening in [New Jersey’s] higher education system overall — at an expansion and enhanced focus,” Paranicas added.

Paranicas said New Jersey’s “innovation ecosystem” received a shot in the arm when the state voted in favor of the Building Our Future Bond Act of 2012.  The law provided $750 million to the state’s public and private colleges and was the first legislation of its kind in a quarter-century.

For more, click here.  For Sheldon’s full NJBIZ story, click here.

 

 

REP. LANCE HOSTS HINJ CEO ON ‘SEVENTH DISTRICT CONGRESSIONAL REPORT’

HINJ’s Dean Paranicas (l.) and  Congressman Leonard Lance

HINJ President and CEO Dean Paranicas was a guest on Rep. Leonard Lance’s (R-7) “Seventh District Congressional Report,” which will be broadcast on various public broadcast stations in the coming days.

Rep. Lance and Paranicas focused on the life sciences’ impact on the state’s economy; the FDA Safety Over Sequestration (SOS) Act, which seeks to exempt FDA user fees from sequestration; and the 21st Century Cures initiative.

For the full story, click here.

 

HINJ AND RX4NJ  HOSTED 2015 COMMISSIONERS FORUM ON FEBRUARY 23

HINJ and the Rx4NJ Partnership hosted the 2015 Commissioners Forum at which New Jersey’s leading healthcare policy makers discussed their departments’ care programs, 2015 plans and more. 

Participating at the Commissioners Forum will be:

  • Connie Calisti-Meyers, Assistant Commissioner, Division of HIV, STD and TB Services, Department of Health
  • Mollie Greene, Director, Clinical Services, Department of Children and Families
  • Valerie Harr, Director, Division of Medical Assistance and Health Services, Department of Human Services

 

THE VALUE OF MEDICAL INNOVATION: SAVING LIVES, SAVING MONEY

Innovation value of medical innovationHINJ President and Chief Executive Officer Dean J. Paranicas has authored an op-ed on the life sciences and the value of medical innovation.

“Medical innovations produced by American life sciences companies have vastly improved the human condition. Our pharmaceutical, biotech, medical technology, device and diagnostics companies have helped people live longer, with less pain and greater quality of life.

“Over the past century, the life sciences has eradicated some of the world’s most dreaded diseases such as polio and smallpox. More recently, the industry has made other diseases such as breast cancer, HIV/AIDS, heart disease and lung cancer no longer the death sentences that they once were.

“With these medical innovations, past and future, comes an often-overlooked benefit: the incalculable billions of dollars in savings to patients, their families, insurers, employers, governments and hospitals in avoided medical expenses associated with keeping people healthy or curing them of a life-long, chronic condition.”

To read Mr. Paranicas’ full op-ed, click here.

 

HINJ OP-ED: LIFE SCIENCES COMMUNITY THRIVING IN NEW JERSEY’S ‘2.0 BUSINESS ENVIRONMENT’

New Jersey sign

The Asbury Park Press has published an op-ed by HINJ President and Chief Executive Officer Dean Paranicas regarding New Jersey’s “2.0 business environment” and its impact on the state’s life sciences community.

“There have been reports that claim that New Jersey is no longer the pharmaceutical powerhouse it used to be, including a recent Asbury Park Press story by Michael L. Diamond …. We disagree. To paraphrase Mark Twain, reports of New Jersey’s demise are greatly exaggerated.

“For decades, New Jersey has rightly earned its reputation as the ‘Medicine Chest of the World’ — and our state leaders are working with the life sciences industry to keep it that way.

Mindful of the life sciences’ significant contributions to the state’s economy and global human health, Governor Christie and his economic development team, together with the State Legislature and its leadership, both Democrats and Republicans, have worked diligently over the past few years to enhance the state’s business climate to retain and grow the many life sciences companies that call New Jersey home — and attract new industry investment.

To read Mr. Paranicas’ full op-ed, click here.

 

HINJ AND NJLSVA HOST 2014 PROCUREMENT CONFERENCE AT ROWAN UNIVERSITY

Through our affiliate organization the New Jersey Life Sciences Vendors Alliance (NJLSVA), HINJ hosted its Annual Vendors Procurement Conference on October 28 at Rowan University. Forty-five vendors attended with 11 companies exhibiting.

Guest speakers included:

  • New Jersey Senate President Stephen Sweeney
  • The Honorable Rob Andrews, former Member of Congress and Of Counsel, Dilworth Paxson
  • Ken Blank, Ph.D., Senior Vice President of Health Sciences, Rowan University.

Please visit HINJ’s Facebook photo album to view photos the 2014 Procurement Conference at Rowan University.

For the complete story, click here.

RESIZE Steve Sweeney and Dean Paranicas

HINJ President and CEO Dean J. Paranicas and
NJ Senate President Stephen Sweeney

 

at life sciences celebration 2014, hinj honors rep. holt, dr. joachim kohn, students 2 science and leukemia & lymphoma society

On October 8, 2014, HINJ honored two New Jersey leaders and two organizations for their contributions in public service, life sciences research, STEM education and patient advocacy.

HINJ’s 2014 honorees were:

  • The Honorable Bob Franks Public Service Award: The Honorable Rush Holt, United States Representative, New Jersey (CD 12)
  • Research: Joachim Kohn, Ph.D., FBSE, Director, New Jersey Center for Biomaterials, Board of Governors Professor of Chemistry, Rutgers, The State University of New Jersey
  • STEM Education: Students 2 Science, Inc.
  • Patient Advocacy: Leukemia & Lymphoma Society’s New Jersey Chapter

HINJ’s guest speaker was Ethan Zohn, CBS “Survivor” winner, cancer crusher and co-founder of Grassroot Soccer.

For the complete story, click here.

ROGER CROP R94A2923 10_08_14

Front (l. to r.): Gina Murdoch, LLS-NJ; HINJ’s Dean Paranicas;
Gina Londino,
LLS-NJ.
Back (l. to r.): HINJ Chair Craig Bleifer, Daiichi Sankyo, Inc.;
Larry Fox, Dr. Paul Winslow, Don Truss, Students 2 Science;
U.S. Rep. Rush Holt; Dr. Joachim Kohn, NJ Center for Biomaterials;
“Survivor” and Cancer Crusher Ethan Zohn; Mike Shevlin, Chair, LLS-NJ.

 

HINJ’S PARANICAS APPEARS ON ‘NJ CAPITOL REPORT’ TO DISCUSS STATE’S LIFE SCIENCES SECTOR

(l. to r.) Steve Adubato, Dean Paranicas and Rafael Pi Roman.

HINJ President and Chief Executive Officer Dean J. Paranicas appears with Emmy Award-winning anchors Steve Adubato and Rafael Pi Roman on “New Jersey Capitol Report” to discuss New Jersey’s life sciences sector.

To view the half-hour episode — Paranicas begins at the 17:45-minute mark — click here.

For the complete story, click here.

 

HINJ ANNOUNCES NEW BOARD, STEERING COMMITTEE LEADERSHIP; DAIICHI SANKYO’s CRAIG BLEIFER NAMED BOARD CHAIR

Craig Bleifer

 

HINJ has announced new officers of its Board of Trustees as well as the leadership of its Steering Committee.

Craig B. Bleifer (photo), Vice President, General Counsel and Secretary, Daiichi Sankyo, Inc., has been named Chair of the HINJ Board of Trustees.

Mr. Bleifer succeeds Kevin T. Rigby, U.S. Country Head Public Affairs, Vice President Public Affairs, Novartis Pharmaceuticals Corporation.

For the complete HINJ leadership story, click here.

 

HINJ HOSTS LT. GOVERNOR GUADAGNO, CABINET MEMBERS FOR ROUNDTABLE DISCUSSION

Photo (left to right): HINJ President and CEO Dean J. Paranicas, HINJ Vice Chair Craig Bleifer (Daiichi Sankyo, Inc.), Lt. Governor Kim Guadagno and HINJ Chair Kevin Rigby (Novartis Pharmaceuticals Corporation).

On June 13, the HealthCare Institute of New Jersey (HINJ) hosted a roundtable discussion featuring New Jersey Lt. Governor Kim Guadagno on the state of the life sciences and prospects for industry growth in the Garden State as part of the HINJ Board of Trustees meeting.

Joining Lt. Governor Guadagno were State Treasurer Andrew P. Sidamon-Eristoff, Labor Commissioner Hal Wirths, New Jersey Economic Development Authority Chief Executive Officer Michele Brown and representatives from the Business Action Center and Choose New Jersey.

For additional information, click here.

 

HINJ Honors Six at Inaugural Life Sciences Celebration

The HealthCare Institute of New Jersey (HINJ) honored five New Jersey leaders and a nationally recognized high school on September 25, 2013, for their contributions in human health, public service, patient advocacy, life sciences, and science, technology, engineering and mathematics (STEM) education.

The awards were presented at HINJ’s inaugural Life Sciences Celebration, which was held at the Renaissance Woodbridge Hotel in Iselin, NJ.

Those recognized included former Governor Thomas H. Kean, the late United States Senator Frank R. Lautenberg, Dr. Christopher J. Molloy, Dr. Joseph R. Bertino, Dr. Debra L. Wentz, and Biotechnology High School.

HINJ was pleased to host three former New Jersey Governors. In addition to Governor Kean, Governor Brendan Byrne and Governor James Florio attended the event.

To read the news story, click here.

 

Password Reset

Please enter your e-mail address. You will receive a new password via e-mail.